Investigating hepatitis E virus seroprevalence in patients with Alzheimer’s disease
Frontiers in Aging Neuroscience · 07.05.2026 · 18
DOI: 10.3389/fnagi.2026.1831973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Aging Neuroscience, online erschienen am 07.05.2026. Verfasst von Tiberiu Daniel Capraru und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chica and Heinz Schaller Research Group, Center of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Hepatitis E virus (HEV) exposure has been linked to neurologic manifestations and dementia. This study aims to clarify a possible association between HEV and Alzheimer’s disease (AD).
Methods
We performed a single-center retrospective case–control study of 453 cognitively impaired adults from southern Germany, comparing anti-HEV IgG seropositivity between patients with AD and those with non-AD cognitive impairment. Associations were evaluated using chi-square testing and multivariable logistic regression, including age-stratified analyses.
Results
Overall HEV IgG seroprevalence was higher in the AD group than in the non-AD group (44.5% vs. 37.7%, p = 0.138), with a significant difference in patients aged 60–69 years (46.5% vs. 35.1%, p = 0.040) but not in those aged 70–79 years (46.7% vs. 50.0%, p = 0.646).
Conclusion
These findings suggest that anti-HEV antibodies are more frequent in younger elderly AD patients compared with cognitively impaired individuals of the same age without AD, raising the hypothesis that prior HEV infection may represent a candidate environmental risk factor for AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chica and Heinz Schaller Research Group, Center of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
- Center for Infectious Diseases, Molecular Virology, Center for Integrative Infectious Disease Research, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
- Department of Clinical Infectious Diseases, Tropical Medicine, Heidelberg, Germany.
- German Centre for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany.
- Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
- Department of Geriatric Psychiatry, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany.
Zitieren
APA
Capraru, T. D., Bauer, T. C., Jordan, P., Weidner, N. M., Oensal, M., Froelich, L., Beisel, C., Hausner, L., & Thi, V. L. D. (2026). Investigating hepatitis E virus seroprevalence in patients with Alzheimer’s disease. Frontiers in Aging Neuroscience, 18. https://doi.org/10.3389/fnagi.2026.1831973
Vancouver
Capraru TD, Bauer TC, Jordan P, Weidner NM, Oensal M, Froelich L, et al. Investigating hepatitis E virus seroprevalence in patients with Alzheimer’s disease. Frontiers in Aging Neuroscience. 2026;18. doi:10.3389/fnagi.2026.1831973
BibTeX
@article{Capraru2026,
author = {Capraru, Tiberiu Daniel and Bauer, Tim Christopher and Jordan, Paula and Weidner, Niklas M and Oensal, Melisa and Froelich, Lutz and Beisel, Claudia and Hausner, Lucrezia and Thi, Viet Loan Dao},
title = {Investigating hepatitis E virus seroprevalence in patients with Alzheimer’s disease},
journal = {Frontiers in Aging Neuroscience},
year = {2026},
volume = {18},
doi = {10.3389/fnagi.2026.1831973}
}
EUVIMED